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Prescribing drugs in primary health care; 
thoughts, information strategy and outcome
Aims: General aim; to investigate whether tailored evidence-based drug information provided to 
general practitioners can be implemented more effectively than evidence-based drug information 
provided	as	usual.	Specific	aims;	to	describe	general	practitioners’	(GPs)	thoughts	on	prescribing
medication and evidence-based drug information: to explore GPs’ attitudes on drug information: 
to	 investigate	 whether	 tailored	 evidence-based	 drug	 information	 can	 influence	 these	 attitudes	 
differently or the prescribing behaviour more effectively than drug information provided as usual.
Methods: Focus-group interviews with a descriptive qualitative approach (I), a cross sectional 
survey using an attitude questionnaire analysed in a multilevel mode and by multiple logistic 
regression (II), and a randomised controlled study (RCTs, III and IV) were used. In the two latter 
medical	information	officers	(MIOs)	providing	drug	information	to	GPs	were	matched	pair-wise	
and randomised into intervention or control groups. The GPs were cluster randomised by their 
MIOs.	The	intervention	MIOs	were	trained	to	provide	evidence-based	drug	information	tailored	
with	motivational	 interviewing	and	 to	 focus	on	 the	benefit	 aspect.	The	 control	MIOs	provided	
evidence-based drug information as usual. Data was collected by an attitude questionnaire (III), 
analysed by the Mann-Whitney test and intention-to-treat. Prescriptions for antihypertensive drugs 
were collected (IV). The change in proportion of ACE inhibitor prescriptions relative to the sum 
of ACE inhibitors and Angiotensin II receptor blockers, during 0–3 and 4–6 months after the 
intervention, was analysed with multiple linear regression, by intention-to-treat and per protocol.
Results: GPs thoughts on prescribing medication and on evidence-based medicine dealt much with 
benefit.	The	core	category	‘prompt	and	pragmatic	benefit’	was	the	utmost	benefit	(I).	A	majority	
of the GPs perceived the information from the industry as too excessive; that the main task of the
industry was to promote sales. The quality of public information was regarded as high and 
useful. Female GPs valued public information to a much greater extent than did male GPs (II). The 
changes in attitudes to drug information did not differ between the two groups (III). Information 
was given to 29% of GPs in both groups (IV). The GPs’ average change in proportion of prescribed 
ACE inhibitors increased in both groups after the intervention.
General conclusions and implications: GPs’ thoughts on evidence-based drug information 
and	prescribing	medication	 relates	 predominantly	 to	 ‘prompt	 and	pragmatic	benefit’;	 delivered	 
immediately, useful and handy. Female GPs valued public drug information much more than 
male GPs did, which might be useful to know in future implementation. GPs’ attitudes on drug 
information did not differ between the groups after the intervention. Neither did the change 
in	 proportion	 of	 prescribed	ACE	 inhibitors	 differ.	 This	 indicates	 no	 benefit	 in	 using	 tailored	 
evidence-based drug information compared to drug information provided as usual.
Keywords: Utilitarianism, prescribing medication, evidence-based medicine, general practitioner, 
pharmaceutical therapy, guide lines, drug information services, primary health care, multilevel 
models, pharmaceutical industry, attitudes, behaviour, public authority drug information, prompt 
and	pragmatic	benefit,	drug	and	therapeutic	committee,	implementation.
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